Costa Rica

Costa Rica has rapidly evolved into a premier global life sciences hub, strategically positioning itself as a leader in medical device manufacturing and high-value innovation.

The country is best known for its robust medtech ecosystem, which accounts for nearly 48% of its national exports and hosts over 100 multinational firms, including seven of the world’s top 30 medical technology leaders.

Beyond manufacturing, Costa Rica is gaining international recognition for pharmaceutical and biotechnology development, driven by a highly skilled workforce and competitive Free Trade Zone (FTZ) incentives.

The nation’s commitment to healthcare innovation is underscored by its world-class clinical research environment and a growing focus on precision medicine and digital health solutions.

Academic research excellence, led by institutions like the University of Costa Rica and the Clodomiro Picado Institute, fuels a pipeline of specialized talent in microbiology, pharmacy and biomedical engineering.

The supply chain resilience of the region is further strengthened by on-site contract manufacturing (CMO) services, specializing in precision tooling, molding and advanced sterilization.

As a pioneer in sustainable manufacturing, Costa Rica aligns its life sciences operations with global ESG (Environmental, Social and Governance) standards, utilizing a 99% renewable electricity matrix.

Foreign investors are increasingly drawn to the country’s legal certainty, political stability and strategic proximity to North American markets.

From R&D and product design to the mass production of Class III implantable devices, the ecosystem offers a comprehensive lifecycle for global life science ventures.

Today, Costa Rica is no longer just a production site but a thriving center for excellence that bridges the gap between scientific discovery and commercial scale.